HUP0102816A2 - Pharmaceutical composition containg brivudine - Google Patents

Pharmaceutical composition containg brivudine

Info

Publication number
HUP0102816A2
HUP0102816A2 HU0102816A HUP0102816A HUP0102816A2 HU P0102816 A2 HUP0102816 A2 HU P0102816A2 HU 0102816 A HU0102816 A HU 0102816A HU P0102816 A HUP0102816 A HU P0102816A HU P0102816 A2 HUP0102816 A2 HU P0102816A2
Authority
HU
Hungary
Prior art keywords
brivudine
pharmaceutical composition
composition containg
containg
pharmaceutical
Prior art date
Application number
HU0102816A
Other languages
Hungarian (hu)
Inventor
Alessandro Casini
Attilio Crea
Bettina Stubinski
Original Assignee
Berlin Chemie Ag
Menarini Ricerche Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Berlin Chemie Ag, Menarini Ricerche Spa filed Critical Berlin Chemie Ag
Publication of HU0102816D0 publication Critical patent/HU0102816D0/en
Publication of HUP0102816A2 publication Critical patent/HUP0102816A2/en
Publication of HUP0102816A3 publication Critical patent/HUP0102816A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HU0102816A 2001-01-03 2001-07-05 Pharmaceutical composition containg brivudine HUP0102816A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2001MI000009A ITMI20010009A1 (en) 2001-01-03 2001-01-03 PHARMACEUTICAL COMPOSITIONS CONTAINING BRIVUDINA FOR SINGLE DAILY ADMINISTRATION

Publications (3)

Publication Number Publication Date
HU0102816D0 HU0102816D0 (en) 2001-09-28
HUP0102816A2 true HUP0102816A2 (en) 2002-10-28
HUP0102816A3 HUP0102816A3 (en) 2005-01-28

Family

ID=11446384

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0102816A HUP0102816A3 (en) 2001-01-03 2001-07-05 Pharmaceutical composition containg brivudine

Country Status (20)

Country Link
AT (1) AT6141U1 (en)
BE (1) BE1014522A5 (en)
CH (1) CH695662A5 (en)
CZ (1) CZ20012464A3 (en)
DK (1) DK177084B1 (en)
ES (1) ES2192456B1 (en)
FI (1) FI20011446A (en)
FR (1) FR2818907B1 (en)
GB (1) GB2370771A (en)
GR (1) GR1004012B (en)
HR (1) HRPK20010345B3 (en)
HU (1) HUP0102816A3 (en)
IE (1) IE20010413A1 (en)
IT (1) ITMI20010009A1 (en)
NL (1) NL1018431C2 (en)
PL (1) PL348480A1 (en)
PT (1) PT102642B (en)
SE (1) SE0102309L (en)
SK (1) SK287043B6 (en)
UA (1) UA76402C2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2239527B1 (en) * 2004-03-01 2006-11-16 M. Cruz Fernandez Gonzalez PHARMACOLOGICAL COMPOSITION OF TOPICAL USE FOR THE TREATMENT OF HERPES ZOSTER.
CN113712928A (en) * 2021-09-29 2021-11-30 重庆市力扬医药开发有限公司 Brivudine drug absorbed through oral mucosa

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0104857A1 (en) * 1982-09-28 1984-04-04 Beecham Group Plc Deoxyuridine compounds, methods for preparing them and their use in medicine
IT1170232B (en) * 1983-10-31 1987-06-03 Anna Gioia Stendardi THERAPEUTIC COMPOSITIONS WITH ANTI-VIRAL ACTIVITY
US5446031A (en) * 1991-04-24 1995-08-29 Yamasa Shuyu Kabushiki Kaisha 1-β-D-arabinofuranosyl-(E)-5-(2-halogenovinyl)uracil derivatives
WO1997025989A1 (en) * 1996-01-19 1997-07-24 Glaxo Group Limited Use of valaciclovir for the manufacture of a medicament for the treatment of genital herpes by a single daily application

Also Published As

Publication number Publication date
ITMI20010009A0 (en) 2001-01-03
FR2818907B1 (en) 2006-05-26
ES2192456A1 (en) 2003-10-01
PT102642A (en) 2002-07-31
PL348480A1 (en) 2002-07-15
CZ20012464A3 (en) 2002-08-14
DK177084B1 (en) 2011-07-11
GB2370771A (en) 2002-07-10
FI20011446A (en) 2002-07-04
HRPK20010345B3 (en) 2005-02-28
AT6141U1 (en) 2003-05-26
DK200101019A (en) 2002-07-04
CH695662A5 (en) 2006-07-31
PT102642B (en) 2003-06-30
SE0102309L (en) 2002-07-04
IE20010413A1 (en) 2003-04-16
UA76402C2 (en) 2006-08-15
FI20011446A0 (en) 2001-07-03
GB0110682D0 (en) 2001-06-20
HRP20010345A2 (en) 2003-08-31
FR2818907A1 (en) 2002-07-05
SE0102309D0 (en) 2001-06-28
SK9572001A3 (en) 2003-03-04
GR20010100322A (en) 2002-10-08
HUP0102816A3 (en) 2005-01-28
ES2192456B1 (en) 2005-02-01
SK287043B6 (en) 2009-10-07
HU0102816D0 (en) 2001-09-28
GR1004012B (en) 2002-11-01
ITMI20010009A1 (en) 2002-07-03
BE1014522A5 (en) 2003-12-02
NL1018431C2 (en) 2002-07-05

Similar Documents

Publication Publication Date Title
EP1450824A4 (en) Pharmaceutical composition
EP1407785A4 (en) Medicinal compositions
HK1072200A1 (en) Pro-micelle pharmaceutical compositions
HK1065944A1 (en) Medicinal compositions
GB0111597D0 (en) Pharmaceutical compositions
HUP0303163A3 (en) Tramadol-based pharmaceutical composition
GB0117057D0 (en) Pharmaceutical composition
HK1065257A1 (en) Medicinal composition
EP1408896A4 (en) Pharmaceutical composition
IL158236A0 (en) Pharmaceutical compositions containing azithromycin and derivatives thereof
GB0129117D0 (en) Pharmaceutical composition
GB0116107D0 (en) Pharmaceutical composition
GB0127805D0 (en) Pharmaceutical composition
GB0104752D0 (en) Pharmaceutical compositions
PL370037A1 (en) Pharmaceutical composition
IL153176A (en) Phenylpiperazines and pharmaceutical compositions comprising them
HUP0102816A2 (en) Pharmaceutical composition containg brivudine
GB0114746D0 (en) Medicinal composition
GB2382302B (en) Pharmaceutical compositions
GB0005382D0 (en) Pharmaceutical composition
IL157411A0 (en) Pharmaceutical composition
EP1413314A4 (en) Medicinal compositions
GB0125061D0 (en) Pharmaceutical composition
HU0103049D0 (en) Pharmaceutical composition
GB0126732D0 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished